Heterogeneous distribution of nuclear triiodothyronine receptors in liver and preadipose cells as evidenced by their reactivity to antibodies against different protein products of erb A oncogenes  by Torresani, J. et al.
Volume 250, number 2, 251-256 FEB 07277 July 1989 
Heterogeneous distribution of nuclear triiodothyronine receptors in 
liver and preadipose cells as evidenced by their reactivity to 
antibodies against different protein products of erb A oncogenes 
J. Torresani, J. Ghysdael*, J. Bismuth, M. Teboul, 0. Ghiringhelli and J. Savary 
INSERM U 38, CNRS URA 178, Laboratoire & Biochimie Midkale, Facultk de Mkdecine, Marseille and 
*INSERM Unit& 186, Institut Pasteur, Lille. France 
Received 21 April 1989 
Polyclonal antibodies raised in rabbits against bacterially produced peptides in the C-terminal region of v-erb A or human 
c-erb A, oncogenes recognize the nuclear triiodothyronine (T3) receptors in the T3-sensitive Ob 17 mouse preadipocyte 
cell line and not in mouse or rat liver. The results confirm the existence of different T3 receptors in different tissues. The 
results also suggest a heterogeneous receptor distribution within the preadipose cell line, with a predominance of c-erb 
&-type species. Antibodies raised against domain 149-227, but not against domain 245-325, impair T3 binding, suggest- 
ing a role for this domain in ligand binding. 
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1. INTRODUCTION 
The multiple developmental and metabolic ac- 
tions of thyroid hormones are thought to be in- 
itiated by the binding of 3,5,3’-triiodothyronine 
(T3) to chromatin-associated receptors [l-3]. The 
nuclear T3 receptors which were only partially 
purified from rat liver [4-61 were described in dif- 
ferent tissues as one class of high-affinity sites for 
T3 in saturation analyses [7] and as an apparently 
homogeneous population in studies of the mole- 
cular mass under non-denaturing conditions [8,9]. 
Nevertheless, when studying the T3 receptors in rat 
liver and mouse preadipocyte cell lines, we noticed 
slight but constant differences in the Sephadex 
G-100 gel filtration behavior [lo]. Furthermore, 
other observations progressively suggested that 
distinct T3 receptors could exist: (i) at least two 
molecular species of about 47 kDa and 57 kDa 
could be seen in SDS-polyacrylamide gel electro- 
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phoreses after affinity labeling of the T3 receptors 
in GHl cells [l l] and rat liver [12]; (ii) slight dif- 
ferences were reported in the relative affinity for 
T3 analogs in different tissues [13]; (iii) in studies 
of the receptor down-regulation by T3, only ap- 
prox. half of the receptor sites were involved in 
several cell types [ 14,151. It was recently suggested 
that the nuclear T3 receptors are encoded by a gene 
family the prototype of which is c-erb &, the pro- 
genitor of the v-erb A oncogene of avian erythro- 
blastosis virus [16,17]. This family is in turn part 
of a large multigene superfamily which comprises 
steroids, vitamin D3 and retinoic acid receptors 
[la]. Molecular cloning and sequence analysis of 
several c-erb A cDNAs have enabled the classifica- 
tion of them into two sub-classes named cy and p, 
the a-type bearing greater similarity to v-erb A 
[ 16-241. Erb A-specific immunosera have been 
raised in rabbits against protein products cor- 
responding to parts of the 3 ‘-coding region of v- 
erb A or human c-erb A, oncogenes [25]. This 
prompted us to comparatively reexplore the 
nuclear T3 receptors in rat and mouse livers and in 
the mouse preadipocyte cell line Ob 17. 
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2. MATERIALS AND METHODS 3. RESULTS 
2.1. Nuclear extracts; nuclear T3 receptor site estimation 
Ob 17 preadipocytes [26] were cultured in Dulbecco’s 
modified Eagle’s medium containing 10% fetal calf serum and 
collected for nuclei purification 3-5 days after confluence 
without hormone addition [ 10). Liver nuclei were purified from 
male Sprague-Dawley rats (200-250 g) and Swiss mice (20 g) 
[8]. Over 80% of the nuclear T3 receptor sites were solubilized 
with 0.4 M KC1 in buffer 1 (20 mM Tris-HCl, 1 mM MgClz, 
2 mM EDTA, pH 7.9) (1 m1/300-5OOpg DNA). T3-binding- 
site concentrations and apparent affinity constants Ka were 
determined in saturation experiments with ‘*‘I-T3 (1.5 ,uCi/pg, 
Amersham, England) [27]. In analytical fractionations and im- 
munoanalyses, the T3 receptors were either detected through 
specifically bound “‘I-T3 when using nuclear extracts prein- 
cubated with 0.3 nM ‘*‘I-T3 (16 h, O’C), or estimated by the 
ability of the fractions to bind lz51-T3 at a near saturating con- 
centration (1 nM) [15]. Non-specific binding was determined 
with a 500-fold excess of unlabeled T3 and subtracted. Bound 
and free 1251-T3 were separated by use of a Dower 1 x 8 ex- 
change resin which binds free T3 (resin test) [27]. 
In comparative analyses, nuclear extracts from 
rat or mouse livers, and from Ob 17 mouse 
2.2. Analytical fractionations 
Gel filtrations were performed on Biogel A 0.5m (100-200 
mesh) columns (10 x 500 mm) in buffer 1 containing 0.1 M 
KCl, 10 mM NaP04, pH 7.9, and 5% glycerol. Sucrose gra- 
dient centrifugations were run in 13 ml of 5-20% sucrose gra- 
dients in buffer 1 containing 0.4 M KCl, for 18 h at 2°C and 
40000 rpm (SW41 rotor). For centrifugations in a denser 
medium 1111, 4 ml of 5-20% sucrose gradients were made in 
buffer 1 containing 9 vols DzO/l vol. HzO, 0.4 M KCl, 10 mM 
DTT, 10% glycerol, and run for 40 h at 4°C and 57000 rpm in 
an SW65 rotor. All analyses were carried out immediately after 
nuclei extraction. 
preadipocytes, bound T3 to one class of sites with 
similar high affinities (Ka 1 to 3 x 10” M-l). 
Biogel A OSm gel filtrations of the same nuclear 
extracts preincubated with ‘*‘I-T3 reproduced 
findings previously obtained when using Sephadex 
G-100 [8, lo]: specifically bound T3 was recovered 
almost exclusively in an included peak eluting later 
with preadipocytes as compared to liver (KaV 0.50 
and 0.38, respectively) (figs lA,2). Furthermore, 
the preadipocyte receptor peak was always found 
to be larger with at least one shoulder at approx. 
0.38 Kay, and evoked a heterogeneity of the T3 
receptor population. After sucrose gradient cen- 
trifugations in HzO, the livers and preadipocyte 
receptors sedimented at 3.6 S without any signifi- 
cant difference; but, under conditions of sucrose 
gradient centrifugation in a denser medium, slight 
differences were constantly reproduced: the liver 
receptors were found in an apparently homogene- 
ous peak whereas the preadipocyte receptors were 
recovered in a slightly slower sedimenting peak 
presenting a shoulder in the position of liver recep- 
tors (fig.lB). This suggested that, under non- 
denaturing conditions, different molecular species 
of T3 receptors could exist that are differently 
distributed between tissues. 
2.3. Antibodies to erb A-encoded proteins and immuno- 
analyses 
Anti-erb A immune rabbit sera (IRS) were raised using pep- 
tides produced in E. coli from DNA fragments derived from the 
3’-coding region of either v-erb A or the human (h) c-erb A, 
oncogenes, as previously described [25]. These peptides cover 
the following amino acid sequences (chicken c-erb A, coor- 
dinates [16]): 149-227 (bp 22MS2-erbA), 228-408 (bp 31MS2-e’bA) 
in v-erb A and 245-325 (bp 18MS2~erbA) in h c-erb &,. Antisera 
27 (IRS 27) and 28 (IRS 28) were derived from two different 
rabbits immunized with bp 22MS2”rbA; antisera 23 (IRS 23) and 
21 (IRS 21) were from two rabbits immunized with bp 
31MSZ-crbA and bp 18MSZ~erbA, respectively [25]. The immu- 
noanalyses were carried out by incubating the nuclear extracts 
with various IRS amounts under conditions of fixed rabbit 
serum concentration (1: 3 (v/v); IRS f normal rabbit serum 
(NRS)) and fiied T3 receptor site concentration (200 PM). After 
16 h at O‘C, the T3 receptors or pre-formed ‘251-T3-receptor 
complexes were analyzed for: (i) level estimation; (ii) behavior 
in gel filtration and sucrose gradient centrifugation; (iii) ability 
to be taken up by sufficient amounts of insoluble protein A in 
Staphylococcus aureus cells (pansorbin, Calbiochem) which did 
not significantly bind unreacted T3 receptors. 
To analyze further a possible heterogeneity of 
the T3 receptors, we looked for a reactivity to erb 
A-specific antisera raised in rabbits against dif- 
ferent peptides corresponding to the C-terminal 
domain of hc-erb A, (hormone-binding domain) 
and the corresponding domain of v-erb A [25]. In 
a first series of assays, nuclear extracts from rat or 
mouse livers, and from preadipocytes, were in- 
cubated with I*?-T3 and then with NRS or the 
various IRS (under conditions of fixed T3, T3- 
binding sites and serum concentrations) and 
analyzed in gel filtration. As shown in fig.2, in- 
cubation of these extracts with NRS did not change 
the T3 receptor elution profiles obtained with un- 
treated extracts (see fig.lA). Similarly, the liver 
receptor profiles were not significantly changed by 
IRS 27 and IRS 21. However, both IRS provoked 
significant and different changes in the preadi- 
pocyte receptor profiles. While IRS 27 provoked a 
decline of the included peak of bound T3 with a 
252 
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Fig. 1. Biogel A 0.5m gel filtration (A) and sucrose gradient 
centrifugation in the presence of D20 (B) of rat liver (0) and 
Ob 17 preadipocytes (0) nuclear extracts. Incubation with 12’1- 
T3 was performed before gel filtration in A and in each fraction 
in B. The data depict specifically bound T3. The position of 
thyroglobulin (Tg), ovalbumin (Ov) and NaI in gel filtration is 
given by the arrows. 
rat liver mouse I iver Ob17 preadipocytes 
parallel increase of the free T3 peak (L approx. 
1.5), IRS 21 partly shifted bound T3 into an ex- 
cluded peak. Neither NRS nor IRS bound ‘251-T3 
to a significant level in the absence of nuclear ex- 
tracts (fig.2, dashed lines in left panels). 
The dissociation of preformed ‘251-T3-receptor 
complexes by IRS 27 in preadipocyte nuclear ex- 
tracts was further evidenced and explored in resin 
tests. As shown in fig.3, the dissociation was 
concentration-dependent and virtually complete at 
10 ,ul IRS 27 per fmol T3-binding site. An essen- 
tially complete dissociation was also obtained with 
IRS 28, a serum directed against the same domain 
as that used to generate IRS 27, at the same relative 
concentration or with an IRS 28-derived fraction 
highly enriched in immunoglobulins. By contrast, 
both IRS only poorly dissociated the complexes 
formed in rat or mouse liver nuclear extracts. 
Taken together, these results strongly suggest an 
authentic antibody effect. Furthermore, a concen- 
tration-dependent depletion of T3-binding sites 
was also observed in preadipocyte nuclear extracts 
preincubated with IRS 27 and then cleared of the 
IgGs by using sufficient amounts of pansorbin. 
t 
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Fig.2. Biogel A 0.5m gel filtration dution profiles of nuclear izsI-T3-receptor complexes of rat or mouse livers and of Ob 17 
preadipocytes after incubation with rabbit serum either normal (NRS) or immune (IRS 27 and 21). The elution of free T3 is shown 
in the righthand panels. The dashed lines in the lefthand panels illustrate the profiles obtained when incubating the respective NRS 
or IRS with ‘251-T3 in the absence of nuclear extract. 
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Fig.3. Effect of increasing concentrations of IRS 27. (-) or IRS 28 (---) added to nuclear extracts of rat liver (0), mouse liver 
(0) or Ob 17 preadipocytes (0) on (left) preformed i’sI-T3-receptor complex level, estimated in resin tests, (right) residual T3-binding 
site level estimated after stripping the IgGs with sufficient amounts of insoluble protein A (pansorbin). An immunoglobulin-enriched 
fraction of IRS 28, reconstituted to the initial volume of serum after two successive salting-outs with (NH&S04 (40% saturation) and 
extensive dialysis with buffer 1, was comparatively analyzed with preadipocytes nuclear extract (7). The data are means f SE of 
triplicate assays. 
This receptor depletion occurred in the same range 
of IRS concentration as described above for 
T3-receptor dissociation. The liver receptors were 
poorly affected (fig.3, right). 
In contrast to the results obtained using IRS 27 
and IRS 28, IRS 21 never dissociated preformed 
‘251-T3-receptor complexes (or impaired T3 bind- 
ing) in either nuclear extract. However, a concen- 
tration-dependent shift of T3-receptor complexes 
from the main included peak, in gel filtration, to 
an excluded one was always observed with the 
preadipocyte receptors (fig.4). A shift of bound T3 
to faster sedimenting species was also observed in 
sucrose gradient centrifugation (not shown). 
Quantitatively, the amount of bound “‘I-T3 
shifted to higher M, species roughly paralleled the 
amount which was found to be retained by pansor- 
bin in immunoprecipitation analyses. These data 
are collected in fig.5. Also apparent in fig.5 is the 
absence of reaction of IRS 21 with liver receptors 
and the fact that, in preadipocytes, only part of the 
T3-receptor complex population seems to be in- 
volved in the immune recognition. When prein- 
cubating the nuclear extracts with IRS 21, then 
pansorbin, the T3-binding sites measured in a 
subsequent incubation of the supernatants with 
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‘251-T3 declined in a similar IRS concentration- 
dependent fashion. Fig.4 also suggests that the 
T3-receptor complexes in preadipocyte nuclear ex- 
tracts are not uniformly recognized by the IRS 21 
antibodies since the shift appears to affect prefer- 
entially the T3-receptor species which elute at Kav 
above 0.38. 
A third type of immune serum, IRS 23, also ex- 
Tg, Ov, Nal, 
“1 
? 6. 
x 
E 
Q 4. 
0 
2 . 
P 
_’ IrcIoyB..? . .  .  . .i , I. 
2 20 30 40 50 
Fractions 
Fig.4. Effect of increasing concentrations of IRS 21 on the gel 
filtration behavior (Biogel A 0.5m) of preadipocytes i*sI- 
T3-receptor complexes: 0 (m-v), 1.5 (m), 3.0 (A---A) and 
5.0 (m) ~1 per fmol T3-binding site. 
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Fig.5. Effect of increasing concentrations of IRS 21 on the 
fraction of preadipocytes ‘251-T3-receptor complexes hifted to 
the excluded peak in gel filtration (0,O separate xperiments) 
or retained by insoluble protein A (0). 
elusively recognized the preadipocyte receptors 
and presented mixed characteristics: partial inhibi- 
tion of T3 binding (and dissociation of T3-receptor 
complexes), and a shift of bound T3 to excluded 
species in Biogel A OSm gel filtration (not shown). 
4. DISCUSSION 
The present study demonstrates, for the first 
time, that polyclonal antibodies directed against 
different peptide portions of the C-terminal part of 
v-erb A or hc-erb A, encoded proteins can recog- 
nize nuclear T3 receptors present in mouse preadi- 
pose cells. The same antibodies did not signifi- 
cantly recognize the receptors present in rat or 
mouse liver, as also recently reported [28]. The an- 
tibodies we used in this study are able to recognize 
the protein products encoded by the c-erb A, gene 
family, whereas only one of them (IRS 23) 
recognizes the products of both cy- and &type c-erb 
A genes ([25,28] and unpublished results). Our 
results therefore favor the hypothesis that most of 
the T3 receptors of mouse preadipocytes belong to 
the a-family. Consistent with recently published 
results [24,28] liver receptors mostly belong to the 
&subtype. 
Our results demonstrate that nuclear T3 recep- 
tors, as defined by in vivo-formed high-affinity 
T3-binding entities, are differently distributed in 
different tissues. These results also suggest hat, 
within a single-cell type, a preadipocyte cell line, a 
heterogeneous expression of T3 receptors might 
exist. The presence of T3 binding molecular species 
generated by a partial degradation of the receptor 
cannot be totally excluded. Nevertheless, the ex- 
istence of different molecular forms of T3 recep- 
tors can also be evoked. Whether this implies the 
coexistence of T3 receptors of the (Y- and /3- 
subfamilies of c-erb A oncogenes or the existence 
of several a-type isoforms is under invest&&on at 
the protein and mRNA levels. Furthermore, we 
reported an increase of the T3 receptor concentra- 
tion during adipose differentiation [lo]; a possible 
evolution of the T3 receptor population has thus to 
be evaluated. 
Interestingly, we found different patterns of in- 
teraction when analyzing the preadipocyte T3 
receptors with the different antisera. IRS.21 an- 
tibodies recognized the preadipocyte receptors 
without impairing T3 binding. Thus,’ the cor- 
responding epitopes in the amino acid sequence 
245-325 of hc-erb A, are not significantly involv- 
ed in the constitution of the hormone binding site. 
IRS 27-28 and IRS 23 antibodies correspond to 
two successive sequences of v-erb A protein cover- 
ing a large part of the C-terminal region following 
the DNA-binding domain [25]. The IRS 23 im- 
munogen (bp 31MS2-erbA) comprises a sequence of 
large homology with that of the IRS 21 immuno- 
gen (bp 22 MS2-erbA) (only two amino acid changes). 
Both types of antisera presumably recognize some 
common epitope(s) involved in receptor recogni- 
tion without impairing T3 binding. However the 
IRS 23 immunogen also generated antibodies 
which impaired T3 binding, an event exclusively 
observed with IRS 27-28 antibodies. The in vitro- 
expressed v-erb A protein was found to be unable 
to bind T3 [16]; but our results suggest hat it con- 
tains important sequences, in distinct regions, for 
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the constitution of a stabilized conformation of the 
T3-binding site, at least in the a-type receptors. It 
is worth noting that a recognition of the liver 
receptors by IRS 27-28 antibodies could not be 
totally excluded: the slight inhibition of T3 binding 
that we observed in their presence could be related 
to either a low affinity in the liver receptors/an- 
tibodies interaction or to the presence of other erb 
A protein species which do not bind T3 as recently 
reported [23] and which compete with the recep- 
tors for antibody recognition. A knowledge of the 
T3-binding site in physiologically expressed T3 
receptors will be gained from mutation-deletion 
experiments as recently reported [29] but also 
needs the development of monospecific and 
monoclonal antibodies to T3 receptor/erb A on- 
cogene products. 
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